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Low-level laser therapy has evidence accumulating about its effectiveness in a variety of medical
conditions. We reviewed 51 double blind randomized controlled trials (RCTs) of laser
treatment. Analysis revealed 58% of trials showed benefit of laser over placebo. However, less
than 5% of the trials had addressed beam disguise or allocation concealment in the laser
machines used. Many of the trials used blinding methods that rely on staff cooperation and are
therefore open to interference or bias. This indicates significant deficiencies in laser trial
methodology. We report the development and preliminary testing of a novel laser
machine that can blind both patient and operator to treatment allocation without staff
participation. The new laser machine combines sealed preset and non-bypassable randomization
codes, decoy lights and sound, and a conical perspex tip to overcome laser diode glow
detection.
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Introduction
Low-level laser therapy in various therapeutic forms is
widely used as a medical treatment modality. In general,
low-level laser machines deliver laser beams in the
0.1–200 mW power range from the end of a hand held
probe, and only require a small battery/charger/timer
unit for normal operation: similar to the modified
machine photographed in Figs 1A and B. In Australia,
one in five general practitioners use acupuncture in their
medical practice, including the use of laser on acupunc-
ture points (1). Laser use has been included alongside
needle acupuncture in post-graduate physician training in
medical acupuncture for more than 15 years, and is
reimbursed as a treatment modality by the Australian
Health Insurance Commission.
Laser treatment approaches include: laser on acupunc-
ture points (2), laser therapy for direct treatment of joint
pain (3) and the non-contact laser irradiation technique
to facilitate skin and wound healing (4). Although the use
of laser on acupuncture points is not yet a proven
substitute for needles, it does have demonstrated effec-
tiveness in a limited range of acupuncture responsive
conditions (5). A small number of randomized controlled
trials (RCTs) have demonstrated significant benefits
including treatment of; neck pain, (6–9) low back pain,
(10) chronic tension headache, (11) fibromyalgia, (12)
enuresis, (5) and post-operative vomiting (2).
The advantages of low-level laser over needles include:
ease of application, usage in anatomically dangerous areas,
and use in needle-phobic patients including children. It is
low cost, non-invasive and safe. (13) General advantages
of laser use in RCTs include: (i) Laser light is invisible
above 770nm and can be switched off or on without visual
recognition by the patient or operator. (ii) Low-level laser
has been shown to have a negligible sensory stimulus,
i.e. patients have difficulty discerning whether they have
received real treatment.
The suitability for trial use has been tested in three
double blind RCTs: a small trial by Irvine et al. (14) and
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properly cited.two larger trials by Chow (N=90) (15) and Brosseau
et al.( N=88) (16) have shown that neither the patient
nor operator can discern whether they are using a laser or
placebo treatment. Therefore when a laser machine is
used correctly it offers a useful way to ensure blinding
and treatment allocation where difficulties exist with
adequate placebos in needle trials (17).
Research Methods and Laser Trials
The most important determinants of well-conducted
RCTs are adequacy of allocation concealment and
blinding procedures. Allocation concealment refers to a
process whereby an unbiased allocation sequence is
implemented in a secure manner that prevents foreknow-
ledge by either the clinician, researcher or trial partici-
pant (18). Generally, allocation concealment appears to
be an important indicator of RCT quality, as an analysis
of RCTs found that those trials that do not detail an
adequate process for allocation concealment show a 40%
increased likelihood of having positive results (19).
Therefore, the design of laser machines and processes
to ensure allocation concealment and double blinding
may be critical to unbiased trial outcomes.
Laser machines delivering visible red light (e.g. using
630nm laser diodes) are not suitable for double-blind
trials because both the patient and operator can see when
the laser is switched on. Even invisible lasers have
problems in RCTs as the laser diode itself glows when
in use. The diode glow can still be seen in the end of
the probe whether or not the resultant beam is visible.
This leaves open the possibility that participants could
gain foreknowledge of treatment allocation and bias the
results. This article reviews the methods of allocation
concealment and blinding used in published laser RCTs.
We then report the features of a novel laser machine that
can blind both patient and operator without the
involvement of extra clinical staff, and the results of a
small study to test this capacity.
Methods and Results of Literature Review
A literature review was performed with systematic
searches of Medline, Embase, Pubmed, Amed, Cinahl,
Ciscom and Cochrane databases. Fifty-one trials of low-
level laser therapy were found that were double blind
clinical RCTs (Tables 1–4).
Analysis of the 51 RCTs showed 30 positive and 21
negative laser trials. However, laser beam detection or
machine randomization had only been modified in less
than 5% of these trials. (Table 1) The laser machine
described by Toya (6) did address the problem of
allocation concealment: a computer was used to turn
the laser beam on/off using randomized numbers that
were unknown to the operator. This is the only trial using
a machine with in-built randomization. The second trial
by Krasheninnikoff et al. (20) used a beam filter to preset
the laser off or on. However, none of the reviewed trials
use a reliable method that addresses the problems of laser
diode glow, blinding and allocation concealment in a
single laser machine.
The remaining 49 trials (Tables 2–4) used less rigorous
methodology for adequate allocation concealment or
blinding: 27 trials used identical laser probes or identical
laser machines; 17 used on/off switches; eight
miscellaneous trials used opaque goggles or other
AB
Figure 1. (A) DBL Laser machine in operation for a placebo treatment. Demonstration of laser probe applied to left hand whilst machine
is activated. The dummy red light is visible on the skin and is shining out of the end of the probe. The probe is activated by pressing the tiny
button visible on the central part of the probe. In this instance, the machine is in full operation, however the invisible infrared laser is switched off
as would be the situation for a placebo treatment. The machine activation light on the laser front panel can be seen at the top left of the
photograph. Aspect; DBL Laser machine is in the background sitting on carry case. (B) Front panel DBL laser machine. Four-digit patient
entry code switch sited in upper right of panel. Indicator lights for machine operation in upper left. Laser probe (white) cord inserted into
bottom right panel. Timer switch - central. Manual key lock and power on/off toggle in lower left of panel. Aspect; DBL Laser machine sitting
on steel carry case.
384 Laser therapy blinding: overview and possible solutionblinding methods. The explanation of blinding was
inadequate in eight trials, nine trials required patient
cooperation, and the operator was not blinded in three of
the trials. All trials required some degree of staff and/or
patient cooperation to conceal treatment allocation and
blinding on the day that the patient was being treated,
allowing the possibility of bias.
These results demonstrate a need for a laser machine
that can properly blind the operator and trial partici-
pants, ensuring concealment of treatment allocation.
Table 2. LLLT trials that use identical laser machines (IDLM) or identical laser probes (IDLP)
Trial Condition Result Possible methodology problems
Basford et al. (21) N=52 Tennis elbow Negative GLO, IDLP, PAT
Basford et al. (10) N=63 Back pain Positive GLO, IDLP, PAT, INC
Basford et al. (22) N=32 Plantar faciitis Negative GLO, IDLP, PAT, INC
Brosseau et al. (23) N=88 OA Hand Positive GLO, IDLP
Carati et al. (24) N=61 Lymphoedema Positive GLO, IDLP
Hansen and Jhoroe (25) N=40 Oro-facial pain Negative GLO, IDLP
Irvine et al. (14) N=15 Carpal tunnel syndrome Negative GLO, IDLP
Laasko et al. (26) N=56 ACTH/ß-Endorphin release Positive GLO, IDLP
Laasko et al. (27) N=41 Pain level and side effects Positive GLO, IDLP
Logdberg-Andersson and Hazel (28) N=176 Myofacial pain Positive GLO, IDLP
Papadopoulos et al. (29) N=29 Tennis elbow Negative GLO, IDLP
Saunders (30) N=24 Supraspinatus tendonitis Positive GLO, IDLP
Quah-Smith et al. (31) N=30 Depression Positive GLO, IDLP
Stelian et al. (32) N=50 OA Knee pain Positive GLO, IDLP
Vecchio et al. (33) N=35 Shoulder pain Negative GLO, IDLP
Bulow and Danneskiold–Samsoe (34) N=29 OA Knee pain Negative GLO, IDLM
Chow et al. (35) N=90 Neck pain Positive GLO, IDLM
Ebneshahidi, et al. (11) N=50 Headache Positive GLO, IDLM
Fernando et al. (36) N=64 Tooth extraction Negative GLO, IDLM
Fukuuchi et al. (37) N=82 Musculoskeletal pain Positive GLO, IDLM
Gallacchi et al. (38) N=15x8 Neck pain Negative GLO, IDLM
Kopera et al. (39) N=44 Chronic leg ulcers Negative GLO, IDLM, PAT
Seidel (8) N=36 Neck pain Positive GLO, IDLM
Soriano (40) N=85 Low back pain Positive GLO, IDLM
Soriano (41) N=71 Neck pain Positive GLO, IDLM, GOG
Vasseljen et al. (42) N=30 Tennis elbow Positive GLO, IDLM
Walker (43) N=36 Chronic pain Positive GLO, IDLM, INC
Other possible methodology problems are included. (N=27).
GLO, Laser diode glow may be visible; IDLP, Identical laser probes; IDLM, Identical laser machines; PAT, Patient cooperation is required; GOG,
Goggles are used; INC, Incomplete explanation of method.
Notes: Total trials=51: references (6, 10, 20–22, 44, 47, 49, 52) (4, 7-9, 11, 14, 23–43, 45, 46, 48, 51, 53–62).
Trials are classified by primary method of blinding.
All trials use invisible laser treatment beam unless otherwise specified.
All laser machines use decoy sound and light as per normal operation.
Three trials: Lundberg, 1987; Haker, 1990; and Haker, 1991- have been removed because of Institutional rulings on scientific practice.
Table 1. LLLT trials where laser machine modifications have positive aspects that improve blinding procedures.
Trial Condition Trial result Positive aspects Possible methodology problems
Krasheninnikoff et al. (20), N=36 Tennis elbow Negative Beam filter used IDLM
Toya et al. (6), N=115 Musculoskeletal pain Positive External computer controlled GLO
(N=2) Possible methodology problems are: IDLM, Identical laser machine used; GLO, laser diode glow may be visible.
Notes: Total trials=51: references (6, 10, 20–22, 44, 47, 49, 52) (4, 7-9, 11, 14, 23–43, 45, 46, 48, 51, 53–62).
Trials are classified by primary method of blinding.
All trials use invisible laser treatment beam unless otherwise specified.
All laser machines use decoy sound and light as per normal operation.
Three trials: Lundberg, 1987; Haker, 1990; and Haker, 1991- have been removed because of Institutional rulings on scientific practice.
eCAM 2008;5(4) 385We now describe the features of a recently developed
laser machine that combines these aims and report a
small study to test these properties.
Novel Laser Machine for RCTs (Figs 1A and
B, 2)
A laser machine suitable for use in RCTs should have the
following attributes:
 An invisible laser beam.
 Disguised laser diode glow.
 Ability to preset randomized number sets and seal
them into the machine.
 Security of internal structures to prevent tampering.
We have developed a new laser machine that is
similar in appearance and function to a normal low-
level laser machine i.e. it has a typically sized hand
held laser probe connected to a power source. It also
has a timer, sound emitter (beep) and key lock as
is normally required by law for laser devices. Added
to this are disguises to overcome the ability of operators
Table 3. LLLT trials that use on/off switches (SWI)
Trial Condition Result Possible methodology problems
A ˜ zdemir et al. (44) N=60 Neck pain Positive GLO, SWI
Basford et al. (45) N=81 Thumb OA pain Negative/Positive GLO, SWI, PAT
Bjordal et al. (46) N=27 Achilles+PGE-2 Positive GLO, SWI
Ceccherelli et al. (7) N=27 Neck pain Positive GLO, SWI
Cetiner et al. (47) N=39 TMJ pain Positive GLO, SWI
Conti et al. (48) N=20 TMJ pain Negative GLO, SWI, INC
de Bie et al. (49) N=217 Ankle sprain Negative GLO, SWI
Dundar (50) N=64 Neck pain Negative GLO, SWI, OPE
Gur et al. (51) N=60 Neck pain Positive GLO, SWI, OPE
Gur et al. (52) N=90 Knee pain Positive GLO, SWI
Klein and Eek (53) N=24 Low back pain Negative GLO, SWI
Kreisler et al. (54) N=52 Dental pain Positive GLO, SWI, PAT
Rogvi-Hansen et al. (55) N=40 Knee pain Negative GLO, SWI, INC
Roynestal et al. (56) N=25 Post-operative pain Negative GLO, SWI, INC
Snyder-Mackler (57) N=24 Skin res/pain Positive GLO, SWI, PAT, GOG
Thornsen et al. (58) N=47 Neck pain Negative GLO, SWI
Waylonis et al. (59) N=62 Myofacial pain Negative GLO, SWI, PAT
(Other possible methodology problems are included. (N=17).
GLO, Laser diode glow may be visible; SWI, Switch on/off; PAT, Patient cooperation is required; OPE, Operator not blinded; GOG, Goggles are
used; INC, Incomplete explanation of method.
Notes: Total trials=51: references (6, 10, 20–22, 44, 47, 49, 52) (4, 7-9, 11, 14, 23–43, 45, 46, 48, 51, 53–62).
Trials are classified by primary method of blinding.
All trials use invisible laser treatment beam unless otherwise specified.
All laser machines use decoy sound and light as per normal operation.
Three trials: Lundberg, 1987; Haker, 1990; and Haker, 1991- have been removed because of Institutional rulings on scientific practice.
Table 4. Miscellaneous LLLT trials (N=5) Other possible methodology problems are included
Trial Condition Result Possible methodology problems
Hopkins et al. (4) N=22 Wound healing Positive GLO, OPE, GOG
Schindl and Neumann (60) N=50 Recurrent herpes Positive GLO, GOG
Snyder-Mackler (57) N=40 Nerve latency Positive GLO, PAT, OPE
Toida et al. (61) N=20 Stomatitis Positive GLO, INC
Lim et al. (62) N=39 Dental pain Negative GLO, INC
GLO, Laser diode glow may be visible; PAT, Patient cooperation is required; OPE, Operator not blinded; INC, Incomplete explanation of method;
GOG, Goggles are used.
Notes: Total trials=51: references (6, 10, 20–22, 44, 47, 49, 52) (4, 7-9, 11, 14, 23–43, 45, 46, 48, 51, 53–62).
Trials are classified by primary method of blinding.
All trials use invisible laser treatment beam unless otherwise specified.
All laser machines use decoy sound and light as per normal operation.
Three trials: Lundberg, 1987; Haker, 1990; and Haker, 1991- have been removed because of Institutional rulings on scientific practice.
386 Laser therapy blinding: overview and possible solutionor patients to see the laser diode glow. These are as
follows:
1. A red decoy light: A biologically inactive (63), red,
non-coherent non-laser light at <0.1mW, is installed
beneath the Perspex cone, next to the diode inside the
end of the probe. (Fig. 1A) This red light acts as a
decoy light and overshadows the small incandescent
glow from the diode. This level of red light is below
threshold for measurable clinical effects (45,59).
2. Conical perspex cone tip: A conical perspex cone tip
has been added to cause partial internal reflection of
both the dummy red light and the laser diode glow;
thereby ‘blending’ the two light sources and making
direct visual detection of the diode glow impossible.
After fitting the conical perspex tip to the laser
probe, the laser diode strength has been reset to an
exit power of 10mW as per the machine’s original
specification.
3. Allocation concealment is ensured using a randomiza-
tion keypad: The randomization schedule is gener-
ated and held by an independent researcher. This
schedule is then built and sealed into each machine
at manufacture. This preset schedule number is a
code that allocates patients into treatment or
placebo groups. Therefore, each participant will be
allocated without the knowledge of the participant
or treating doctor/operator. Each participant is
allocated by entering their particular patient code
number into the keypad on the front of the laser
machine. (Fig. 1B) As mistakes can occur with the
keypad number entry, the patients are asked to
check their keypad number with the operator before
each treatment.
4. Decoys: When the machine is activated for treat-
ment, it makes an audible beep and the console
lights turn on; indicating to the patient that the
machine is switched on. These decoys are in
operation whether or not the real laser beam is
activated. (Fig. 1B)
5. Non-bypass system: the four-digit patient code
switch cannot be bypassed. It is impossible for the
treatment group allocation to be altered after being
preset and sealed in manufacture.
6. Equipment testing: the preset randomization sche-
dule can be checked by an independent researcher
prior to the commencement of the trial.
Method of Laser Machine Testing
To test our novel machine in its capacity to ensure
allocation concealment and blinding, a sample of 20
doctors was asked to participate in a double blind test.
The group was an opportunistic sample of doctors who
practiced medical acupuncture and presented for a
discussion group on medical acupuncture treatment in
chronic pain. All of them were familiar with the usage
and risks of low-power lasers and consented to partici-
pate. There were no refusals. They knew there were
deliberate disguises in place i.e. the decoy red light and
perspex cone. Participants were asked to examine
the laser machine and activate the laser whilst switched
between two-unknown preset positions that switched
the real laser beam off and on. The participants were
asked to determine whether they could see the laser
diode operating through the perspex cone. The
possible responses: either ‘on’, ‘off’ or ‘cannot tell’,
were recorded.
Results and Discussion of Laser Machine
Testing
In this preliminary study, none of the 20 laser familiar
participants could see the operation of the laser diode.
This is supportive evidence that the laser diode disguise is
effective and overcomes this important problem in double
blinding laser trials. The preset concealed randomization-
coding system also worked effectively.
Conclusions
Analysis of 51 double blind RCTs of laser treatment
revealed 58% showed benefit of laser over placebo.
However, less than 5% of the trials had addressed beam
disguise or allocation concealment in the laser machines
used. This indicates significant deficiencies in laser trial
methodology. A new laser machine has been developed
that can blind both patient and operator to treatment
allocation without staff participation. Preliminary testing
has verified that the laser machine diode operation could
not be detected, and the preset sealed randomization-
coding system was effective. We consider this machine
could be a useful tool in conducting double blind RCTs,
however a larger clinical study should be undertaken
before it can be fully validated as a trial instrument.
DBL laser specifications:
830nm Gallium Aluminium Arsenide infrared laser machine. 
Probe 10 mW probe exit strength.
Standard usage per point = 0.2 J.
Four digit switch for preset sealed randomisation codes/treatment allocation.
Hand held probe with aluminium casing and conical perspex tip.
Decoy red light in probe tip offset from laser path.
Decoy beeping sound preset—always on—when probe activated.
Figure 2. DBL Laser machine specifications.
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